share_log

长春高新:关于子公司注射用金纳单抗上市申请获得受理的公告

Changchun Hi-Tech: Announcement on the acceptance of the subsidiary's application for marketing of injectable kinazumab

深证信a股 ·  Apr 11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more